<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02642705</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A01482-45</org_study_id>
    <nct_id>NCT02642705</nct_id>
  </id_info>
  <brief_title>High Intensity Interval Training and Hypoxic Conditioning in Obese Patients</brief_title>
  <acronym>HYPINT</acronym>
  <official_title>New Treatment Modalities in Obese Patients: High Intensity Interval Training and Hypoxic Conditioning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aims at evaluating the effect of two innovative treatment strategies in
      obese patients: high intensity interval training and hypoxic conditioning. Obese patients
      will be randomized in groups performing high intensity interval training, constant load
      training, hypoxic conditioning or placebo normoxic conditioning for 8 weeks. The effects of
      the interventions will be measured regarding exercise tolerance, blood pressure, body
      composition, metabolic status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      120 obese patients will be randomized to 6 intervention groups. Each group will follow an
      8-week intervention (3 session per week) with either high intensity interval training in
      normoxia or hypoxia, constant load exercise training in normoxia or hypoxia, hypoxic or
      normoxic (placebo) conditioning at rest. Exercise capacity, metabolic status, blood pressure,
      vascular function and physical activity will be assessed before and after the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal exercise capacity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Maximal oxygen consumption during an incremental exercise test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic status</measure>
    <time_frame>8 weeks</time_frame>
    <description>Blood lipids, glycemia, HOMA index, oxydative stress and inflammatory status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>8 weeks</time_frame>
    <description>MRI fat free mass and adipose tissue measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>8 weeks</time_frame>
    <description>24 h ambulatory blood pressure mesurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular function</measure>
    <time_frame>8 weeks</time_frame>
    <description>Post-ischemic hyperemia (Endo-Pat) and pulse wave velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Spontaneous physical activity measured by accelerometry</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>High intensity interval training N</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High intensity interval training N: The intervention consists in 8-week exercise training, 3 times a week for one hour, according to a high intensity interval training protocol (1 min ON at 100% maximal power output, 1 min OFF), breathing ambient air (normoxia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High intensity interval training H</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High intensity interval training H: The intervention consists in 8-week exercise training, 3 times a week for one hour, according to a high intensity interval training protocol (1 min ON at 100% maximal power output, 1 min OFF), breathing hypoxic air (about 3 500 m of altitude)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Constant load exercise training N</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Constant load exercise training N: The intervention consists in 8-week exercise training, 3 times a week for one hour, according to a constant load training protocol (50% maximal power output), breathing ambient air (normoxia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Constant load exercise training H</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Constant load exercise training H: The intervention consists in 8-week exercise training, 3 times a week for one hour, according to a constant load training protocol (50% maximal power output), breathing hypoxic air (about 3 500 m of altitude)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypoxic conditioning at rest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hypoxic conditioning at rest : The intervention consists in 8-week conditioning period, 3 times a week, hypoxic breathing for one hour (about 4500 m of altitude) while seating quietly</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normoxic conditioning at rest</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Normoxic conditioning at rest : The intervention consists in 8-week conditioning period, 3 times a week, normoxic breathing for one hour (ambient air) while seating quietly</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High intensity interval training N</intervention_name>
    <description>Exercise training and ambient air breathing</description>
    <arm_group_label>High intensity interval training N</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High intensity interval training H</intervention_name>
    <description>Exercise training and hypoxic breathing</description>
    <arm_group_label>High intensity interval training H</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Constant load exercise training N</intervention_name>
    <description>Exercise training and ambient air breathing</description>
    <arm_group_label>Constant load exercise training N</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Constant load exercise training H</intervention_name>
    <description>Exercise training and hypoxic breathing</description>
    <arm_group_label>Constant load exercise training H</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoxic conditioning at rest</intervention_name>
    <description>Hypoxic breathing at rest</description>
    <arm_group_label>Hypoxic conditioning at rest</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normoxic conditioning at rest</intervention_name>
    <description>Normoxic breathing at rest (placebo)</description>
    <arm_group_label>Normoxic conditioning at rest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI between 27 and 35 kg/m²

          -  Physical activity &lt;2 hours/week

          -  No chronic disease or treatment able to interfere with inflammation and metabolic
             perturbatiosn associated with obesity

        Exclusion Criteria:

          -  Diabetes mellitus treated with insulin

          -  Auto-immune or inflammatory diseases requiring long term therapy

          -  Unstable dysthyroidism

          -  Bariatric surgery within the past 18 months

          -  Tumoral, inflammatory, infectious, cardiac, respiratory, kidney, digestive disease

          -  Untreated sleep apnea
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Wuyam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samuel Verges, PhD</last_name>
    <phone>0476766860</phone>
    <email>sverges@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patrice Flore, PhD</last_name>
    <phone>0476768921</phone>
    <email>pflore@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <state>Rhone Alpes</state>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Verges, PhD</last_name>
      <phone>0476766860</phone>
      <email>sverges@chu-grenoble.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Verges S, Chacaroun S, Godin-Ribuot D, Baillieul S. Hypoxic Conditioning as a New Therapeutic Modality. Front Pediatr. 2015 Jun 22;3:58. doi: 10.3389/fped.2015.00058. eCollection 2015. Review.</citation>
    <PMID>26157787</PMID>
  </reference>
  <reference>
    <citation>Weston KS, Wisløff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med. 2014 Aug;48(16):1227-34. doi: 10.1136/bjsports-2013-092576. Epub 2013 Oct 21. Review.</citation>
    <PMID>24144531</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 24, 2015</study_first_submitted>
  <study_first_submitted_qc>December 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>December 24, 2015</last_update_submitted>
  <last_update_submitted_qc>December 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

